Browse By: Country ι Category ι Publisher ι Tag
Home  »  Pharmaceutical

Pharmaceutical Market Research Reports

The global pharmaceutical market is almost a trillion dollar industry. The pharmaceutical market has been playing a very important role in the area of scientific advancement and has contributed significantly to economic growth all across the globe. The global pharmaceutical market consists of a wide range of mid-sized, and big companies, and multinational corporations like biopharmaceutical firms, pharmaceutical companies, virtual pharmas, generic manufacturer
biotechnology firms. The pharmaceutical market also includes various service and ancillary support firms which provide raw materials, undertake contract research projects, contract sales, manufacturing technologies, and regulatory guidance. 


The global pharmaceutical market is witnessing satisfactory growth owing to factors like high incidence of chronic and contagious diseases, and rising life expectancy. Research and development related investments are also taking place in the pharmaceutical market due to rising demand for innovative and better drugs. An emerging segment in the pharmaceutical market is that of biopharmaceuticals which is extensively applied in proteomics, drug discovery, and genomics. 


The highest market share in the global pharmaceutical market is held by the US. It is expected that emerging economies of the Asia Pacific like India and China will report high rates of growth in the forthcoming years. This is because huge pharmaceutical companies these days are outsourcing their R&D projects to these economies for better cost efficiency and to efficiently utilize the scientific labor pool in these economies. 


The growth of the global pharmaceutical market gets affected due to regulatory measures, price pressures, and high demand for innovative drugs, short product lifecycles, and weak drug pipelines. 


Marketresearchreports.biz provides thousands of detailed and exhaustive market research reports on the global pharmaceutical market that add immense value to your vital business strategies and decisions. These reports contain accurate data and facts that enable you to take the right business decision.

More

United States Anesthesia Drugs Market & Forecast
Anesthesia drugs are used during tests and surgical operations to induce sleep, which prevents pain and discomfort and enables a wide range of medical procedures to be performed. Local Anesthesia and General Anesthesia are the two commonly used types of anesthesia. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation.  United States anesthesia drugs market is expected to be more than US$ 3 Billion by 2018. General Intravenous Anesthesia drugs market is dominating the United States anesthesia drugs market. In further classification of General Intravenous Anesthesia Drugs market, Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top contributors to intraven
Published Date: Dec 2014
Published By: Renub Research

Price: $1450
Emesis (Vomiting) - Pipeline Review, H2 2014
Global Markets Directs, Emesis (Vomiting) Pipeline Review, H2 2014, provides an overview of the Emesis (Vomiting)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Emesis (Vomiting), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Emesis (Vomiting) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Myasthenia Gravis - Pipeline Review, H2 2014
Global Markets Directs, Myasthenia Gravis Pipeline Review, H2 2014, provides an overview of the Myasthenia Graviss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myasthenia Gravis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Malignant Glioma - Pipeline Review, H2 2014
Global Markets Directs, Malignant Glioma Pipeline Review, H2 2014, provides an overview of the Malignant Gliomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Glioma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014
Global Markets Directs, Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Pipeline Review, H2 2014, provides an overview of the Transitional Cell Carcinoma (Urothelial Cell Carcinoma)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma) and special features on late-stage and discontinued projects. Global Market
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Retinal Degeneration - Pipeline Review, H2 2014
Global Markets Directs, Retinal Degeneration Pipeline Review, H2 2014, provides an overview of the Retinal Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Retinal Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinal Degeneration and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Restenosis - Pipeline Review, H2 2014
Global Markets Directs, Restenosis Pipeline Review, H2 2014, provides an overview of the Restenosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Restenosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Restenosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Tauopathies - Pipeline Review, H2 2014
Global Markets Directs, Tauopathies Pipeline Review, H2 2014, provides an overview of the Tauopathiess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tauopathies, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tauopathies and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2014
Global Markets Directs, Nasopharyngitis (Common Cold) Pipeline Review, H2 2014, provides an overview of the Nasopharyngitis (Common Cold)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nasopharyngitis (Common Cold), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nasopharyngitis (Common Cold) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and n
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014
Global Markets Directs, Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Pipeline Review, H2 2014, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) and special features on late-stage and discontinued projects. Globa
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014
Global Markets Directs, Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H2 2014, provides an overview of the Chemotherapy Induced Peripheral Neuropathys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Peripheral Neuropathy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Seasonal Allergic Rhinitis - Pipeline Review, H2 2014
Global Markets Directs, Seasonal Allergic Rhinitis Pipeline Review, H2 2014, provides an overview of the Seasonal Allergic Rhinitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Seasonal Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Seasonal Allergic Rhinitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Cedar Pollen Allergy - Pipeline Review, H2 2014
Global Markets Directs, Cedar Pollen Allergy Pipeline Review, H2 2014, provides an overview of the Cedar Pollen Allergys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cedar Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cedar Pollen Allergy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Sarcoidosis - Pipeline Review, H2 2014
Global Markets Directs, Sarcoidosis Pipeline Review, H2 2014, provides an overview of the Sarcoidosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sarcoidosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Plague - Pipeline Review, H2 2014
Global Markets Directs, Plague Pipeline Review, H2 2014, provides an overview of the Plagues therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plague and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Ma
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Periodontitis - Pipeline Review, H2 2014
Global Markets Directs, Periodontitis Pipeline Review, H2 2014, provides an overview of the Periodontitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Periodontitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Periodontitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Myotonic Dystrophy - Pipeline Review, H2 2014
Myotonic Dystrophy - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Myotonic Dystrophy - Pipeline Review, H2 2014, provides an overview of the Myotonic Dystrophys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myotonic Dystrophy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Intermittent Claudication - Pipeline Review, H2 2014
Intermittent Claudication - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Intermittent Claudication - Pipeline Review, H2 2014, provides an overview of the Intermittent Claudications therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Intermittent Claudication, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Intermittent Claudication and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Brain Injury - Pipeline Review, H2 2014
Brain Injury - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Brain Injury - Pipeline Review, H2 2014, provides an overview of the Brain Injurys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Androgenic Alopecia - Pipeline Review, H2 2014
Androgenic Alopecia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Androgenic Alopecia - Pipeline Review, H2 2014, provides an overview of the Androgenic Alopecias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Androgenic Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Androgenic Alopecia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014, provides an overview of the Hospital Acquired Pneumonia (HAP)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hospital Acquired Pneumonia (HAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hospital Acquired Pneumonia (HAP) and special features on late-stage and discontinued projects.Global Markets Directs report features inves
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Pompe Disease - Pipeline Review, H2 2014
Pompe Disease - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Pompe Disease - Pipeline Review, H2 2014, provides an overview of the Pompe Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pompe Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pompe Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Rhinovirus Infection - Pipeline Review, H2 2014
Rhinovirus Infection - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Rhinovirus Infection - Pipeline Review, H2 2014, provides an overview of the Rhinovirus Infections therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Rhinovirus Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rhinovirus Infection and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Chronic Urticaria Or Hives - Pipeline Review, H2 2014
Chronic Urticaria Or Hives - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chronic Urticaria Or Hives - Pipeline Review, H2 2014, provides an overview of the Chronic Urticaria Or Hivess therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Urticaria Or Hives, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Urticaria Or Hives and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2014, provides an overview of the Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Methicillin-Suscept
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Bone Fracture - Pipeline Review, H2 2014
Bone Fracture - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Bone Fracture - Pipeline Review, H2 2014, provides an overview of the Bone Fractures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bone Fracture, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Fracture and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Hyperphosphatemia - Pipeline Review, H2 2014
Hyperphosphatemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hyperphosphatemia - Pipeline Review, H2 2014, provides an overview of the Hyperphosphatemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hyperphosphatemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyperphosphatemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000
Japan Tobacco Inc. - Product Pipeline Review - 2014
Global Markets Directs, Japan Tobacco Inc. Product Pipeline Review 2014, provides an overview of the Japan Tobacco Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Japan Tobacco Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourc
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Kaken Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Kaken Pharmaceutical Co., Ltd. Product Pipeline Review 2014, provides an overview of the Kaken Pharmaceutical Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kaken Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bu
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2014
Global Markets Directs, D. Western Therapeutics Institute, Inc. Product Pipeline Review 2014, provides an overview of the D. Western Therapeutics Institute, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of D. Western Therapeutics Institute, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
PharmaEssentia Corporation - Product Pipeline Review - 2014
Global Markets Directs, PharmaEssentia Corporation Product Pipeline Review 2014, provides an overview of the PharmaEssentia Corporations pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of PharmaEssentia Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using da
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Creabilis SA - Product Pipeline Review - 2014
Global Markets Directs, Creabilis SA Product Pipeline Review 2014, provides an overview of the Creabilis SAs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Creabilis SAs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Mar
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
NovaBay Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, NovaBay Pharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the NovaBay Pharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NovaBay Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Bukwang Pharm.Co., Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Bukwang Pharm.Co., Ltd. Product Pipeline Review 2014, provides an overview of the Bukwang Pharm.Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Bukwang Pharm.Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
High Point Pharmaceuticals, LLC - Product Pipeline Review - 2014
Global Markets Directs, High Point Pharmaceuticals, LLC Product Pipeline Review 2014, provides an overview of the High Point Pharmaceuticals, LLCs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of High Point Pharmaceuticals, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
iCo Therapeutics Inc. - Product Pipeline Review - 2014
Global Markets Directs, iCo Therapeutics Inc. Product Pipeline Review 2014, provides an overview of the iCo Therapeutics Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of iCo Therapeutics Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Onyx Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, Onyx Pharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the Onyx Pharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Onyx Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using da
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Shin Nippon Biomedical Laboratories, Ltd. Product Pipeline Review 2014, provides an overview of the Shin Nippon Biomedical Laboratories, Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Shin Nippon Biomedical Laboratories, Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
ASKA Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Global Markets Directs, ASKA Pharmaceutical Co., Ltd. Product Pipeline Review 2014, provides an overview of the ASKA Pharmaceutical Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ASKA Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usi
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2014
Global Markets Directs, Vanda Pharmaceuticals Inc. Product Pipeline Review 2014, provides an overview of the Vanda Pharmaceuticals Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Vanda Pharmaceuticals Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, RegeneRx Biopharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the RegeneRx Biopharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of RegeneRx Biopharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The rep
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
biOasis Technologies Inc. - Product Pipeline Review - 2014
Global Markets Directs, biOasis Technologies Inc. Product Pipeline Review 2014, provides an overview of the biOasis Technologies Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of biOasis Technologies Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Redbiotec AG - Product Pipeline Review - 2014
Global Markets Directs, Redbiotec AG Product Pipeline Review 2014, provides an overview of the Redbiotec AGs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Redbiotec AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Mar
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Can-Fite BioPharma Ltd. - Product Pipeline Review - 2014
Global Markets Directs, Can-Fite BioPharma Ltd. Product Pipeline Review 2014, provides an overview of the Can-Fite BioPharma Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Can-Fite BioPharma Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Adienne Pharma & Biotech - Product Pipeline Review - 2014
Global Markets Directs, Adienne Pharma & Biotech Product Pipeline Review 2014, provides an overview of the Adienne Pharma & Biotechs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Adienne Pharma & Biotechs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Scancell Holdings Plc - Product Pipeline Review - 2014
Global Markets Directs, Scancell Holdings Plc Product Pipeline Review 2014, provides an overview of the Scancell Holdings Plcs pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Scancell Holdings Plcs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Auspex Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Global Markets Directs, Auspex Pharmaceuticals, Inc. Product Pipeline Review 2014, provides an overview of the Auspex Pharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Auspex Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
BioApex, s.r.o. - Product Pipeline Review - 2014
BioApex, s.r.o. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, BioApex, s.r.o. - Product Pipeline Review - 2014, provides an overview of the BioApex, s.r.o.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of BioApex, s.r.o.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Blueprint Medicines - Product Pipeline Review - 2014
Blueprint Medicines - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Blueprint Medicines - Product Pipeline Review - 2014, provides an overview of the Blueprint Mediciness pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Blueprint Mediciness, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Cerecor Inc. - Product Pipeline Review - 2014
Cerecor Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Cerecor Inc. - Product Pipeline Review - 2014, provides an overview of the Cerecor Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Cerecor Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014
Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Grupo Ferrer Internacional, S.A. - Product Pipeline Review - 2014, provides an overview of the Grupo Ferrer Internacional, S.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Grupo Ferrer Internacional, S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe coverin
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Immune Design Corp. - Product Pipeline Review - 2014
Immune Design Corp. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Immune Design Corp. - Product Pipeline Review - 2014, provides an overview of the Immune Design Corp.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immune Design Corp.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Kite Pharma, Inc. - Product Pipeline Review - 2014
Kite Pharma, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Kite Pharma, Inc. - Product Pipeline Review - 2014, provides an overview of the Kite Pharma, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Kite Pharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The re
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
OncoSec Medical Inc. - Product Pipeline Review - 2014
OncoSec Medical Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, OncoSec Medical Inc. - Product Pipeline Review - 2014, provides an overview of the OncoSec Medical Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of OncoSec Medical Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014
Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Panmira Pharmaceuticals, LLC. - Product Pipeline Review - 2014, provides an overview of the Panmira Pharmaceuticals, LLC.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Panmira Pharmaceuticals, LLC.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Phosphagenics Limited - Product Pipeline Review - 2014
Phosphagenics Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Phosphagenics Limited - Product Pipeline Review - 2014, provides an overview of the Phosphagenics Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Phosphagenics Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
RAPID Pharmaceuticals AG - Product Pipeline Review - 2014
RAPID Pharmaceuticals AG - Product Pipeline Review - 2014SummaryGlobal Markets Directs, RAPID Pharmaceuticals AG - Product Pipeline Review - 2014, provides an overview of the RAPID Pharmaceuticals AGs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of RAPID Pharmaceuticals AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and near
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Rodos BioTarget GmbH - Product Pipeline Review - 2014
Rodos BioTarget GmbH - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Rodos BioTarget GmbH - Product Pipeline Review - 2014, provides an overview of the Rodos BioTarget GmbHs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Rodos BioTarget GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Biosidus S.A. - Product Pipeline Review - 2014
Biosidus S.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Biosidus S.A. - Product Pipeline Review - 2014, provides an overview of the Biosidus S.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Biosidus S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Piramal Enterprises Limited - Product Pipeline Review - 2014
Piramal Enterprises Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Piramal Enterprises Limited - Product Pipeline Review - 2014, provides an overview of the Piramal Enterprises Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Piramal Enterprises Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
ReGenX Biosciences, LLC - Product Pipeline Review - 2014
ReGenX Biosciences, LLC - Product Pipeline Review - 2014SummaryGlobal Markets Directs, ReGenX Biosciences, LLC - Product Pipeline Review - 2014, provides an overview of the ReGenX Biosciences, LLCs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of ReGenX Biosciences, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
PharmaIN Corporation - Product Pipeline Review - 2014
PharmaIN Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, PharmaIN Corporation - Product Pipeline Review - 2014, provides an overview of the PharmaIN Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of PharmaIN Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Teijin Pharma Limited - Product Pipeline Review - 2014
Teijin Pharma Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Teijin Pharma Limited - Product Pipeline Review - 2014, provides an overview of the Teijin Pharma Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Teijin Pharma Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Recordati S.p.A. - Product Pipeline Review - 2014
Recordati S.p.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Recordati S.p.A. - Product Pipeline Review - 2014, provides an overview of the Recordati S.p.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Recordati S.p.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $1500
Fast Growing China Pharmaceutical Market
The pharmaceutical industry in China, which is the world's second largest pharmaceutical market after the US, promises robust growth in the coming years. The growth is boosted by the growing aging population, increasing wealth and government reforms. It is expected that in 2020 33% of the Chinese population will be 50 years or older as compared with 24% in 2010. Also chronic illnesses such as hypertension and diabetes are on the rise. The sector is going through an exciting phase with the government implementing various healthcare reforms and local companies becoming increasingly competitive. Spending in the sector is expected to increase from USD 357 billion in 2011 to approximately USD 1 trillion in 2020. Why should the report be purchased? The report ""Fast Growing China Pharma
Published Date: Dec 2014
Published By: Smart Research Insights

Price: $1000
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - DenmarkSummaryGlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by G
Published Date: Dec 2014
Published By: GlobalData

Price: $1995
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023SummaryColorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers in men and second highest in women. CRC is a high mortality cancer, with mortality rates just behind lung, liver, and stomach cancers in men, and breast and lung cancers in women. Most cases of CRC start as small adenoma polyps in the inner lining of the colon or rectum. CRC screening aims to identify and remove polyps when they are small to prevent the polyps from changing into cancer and has been shown to be effective in reducing the mortality from CRC.GlobalData epidemiologists forecast that the number of total diagnosed incident cases of CRC in the 8MM is expected to grow from 758,062 case
Published Date: Dec 2014
Published By: GlobalData

Price: $3995
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023SummaryRheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the bodys immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, pain, and redness, which can cause bone and cartilage erosion, and joint deformity. The disease can lead to premature mortality, disability, and decreased quality of life.GlobalData epidemiologists forecast an increase in the total prevalent cases of RA in the 8MM, from 12,901,398 total prevalent cases in 2013 to 14,896,291 total prevalent cases in 2023, at an Annual Growth Rate (AGR) of 1.55% over the forecast period. GlobalData epidemiologists also forecast an increase in the diagnosed prev
Published Date: Dec 2014
Published By: GlobalData

Price: $3995
EpiCast Report: Acromegaly and Gigantism - Epidemiology Forecast to 2023
EpiCast Report: Acromegaly and Gigantism - Epidemiology Forecast to 2023SummaryAcromegaly and gigantism are rare disorders of the pituitary gland characterized by the hypersecretion of growth hormone (GH). GH excess beginning in adulthood is known as acromegaly, whereas GH excess beginning during childhood is known as gigantism.GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of acromegaly in the 6MM from 25,354 diagnosed prevalent cases in 2013 to 26,884 diagnosed prevalent cases in 2023, at an Annual Growth Rate (AGR) of 0.60% in the forecast period. Similarly, GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of gigantism in the 6MM from 591 diagnosed prevalent cases in 2013 to 621 diagnosed prevalent cases in 2023, at an AG
Published Date: Dec 2014
Published By: GlobalData

Price: $3995
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics
The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter asset purchase deals.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and
Published Date: Dec 2014
Published By: Current Partnering

Price: $2995
Cancer Diagnostics Partnering Terms and Agreements
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value   The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides an understanding and analysis of how and why companies enter cancer diagnostics partnering deals. The majority of dea
Published Date: Dec 2014
Published By: Current Partnering

Price: $2995
Mental Illness Drugs Markets in China
China's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled. The primary and secondary research is done in China in order to access up-to-date gov
Published Date: Dec 2014
Published By: Asia Market Information & Development Company

Price: $4000
Hypertension Drugs Markets in China
China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled. The primary and secondary research is done in China in order to access up-to-date gover
Published Date: Dec 2014
Published By: Asia Market Information & Development Company

Price: $4000
Opioids Market Overview to 2023 - Opioids in Emerging Markets
The report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential. Emphasis on restricting access to controlled drugs is much higher in emerging markets than in developed nations, resulting in a level of consumption that is too low to meet pain-control requirements even in cases of terminal illness. There is a high level of unmet need for pain control in both cancer and HIV/AIDS, and serious concerns have been raised regarding inadequate pain management in the emerging markets. However, this is
Published Date: Nov 2014
Published By: CBR Pharma Insights

Price: $2995
Distribution on the pharmaceutical Market in Poland 2014 Development forecasts for 2014-2019
Discover opportunity on Poland’s pharmaceutical distribution market.  Report describes diverse operations; forecasts development for 2014-2019. What percentage of pharmacies in Poland are chain-owned and operated? Which chains maintain the largest number of stores? How many pharmacies are currently in operation in Poland? How does this number compare with the total number of potential consumers? Which wholesaler/pharmacy relationships are most important? Which types of loyalty schemes are most effective? How valuable is the online segment of this market? How have regulations affected online distribution? For complete answers to these questions and many more, turn to Distribution on the pharmaceutical market in Poland 2014, Development forecasts for 2014-2019, the latest
Published Date: Nov 2014
Published By: PMR

Price: $2660
Hemorrhagic Fever - Pipeline Review, H2 2014
Hemorrhagic Fever - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hemorrhagic Fever - Pipeline Review, H2 2014, provides an overview of the Hemorrhagic Fevers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hemorrhagic Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemorrhagic Fever and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and special features on late-stage and discon
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Metastatic Breast Cancer - Pipeline Review, H2 2014
Metastatic Breast Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Metastatic Breast Cancer - Pipeline Review, H2 2014, provides an overview of the Metastatic Breast Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Breast Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering o
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014
H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014, provides an overview of the H5N1 Infection (Avian Influenza)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for H5N1 Infection (Avian Influenza), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for H5N1 Infection (Avian Influenza) and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Anxiety Disorders - Pipeline Review, H2 2014
Anxiety Disorders - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Anxiety Disorders - Pipeline Review, H2 2014, provides an overview of the Anxiety Disorderss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anxiety Disorders and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Allergic Asthma - Pipeline Review, H2 2014
Allergic Asthma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Allergic Asthma - Pipeline Review, H2 2014, provides an overview of the Allergic Asthmas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Allergic Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Asthma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Anthrax - Pipeline Review, H2 2014
Anthrax - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Anthrax - Pipeline Review, H2 2014, provides an overview of the Anthraxs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anthrax, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anthrax and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Bacterial Pneumonia.
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014, provides an overview of the Wet (Neovascular / Exudative) Macular Degenerations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration and special features
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Community-Acquired Infections Global Clinical Trials Review, H2, 2014
Community-Acquired Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Community-Acquired Infections Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Infections. This report is built using data and informat
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Esophageal Cancer - Pipeline Review, H2 2014
Esophageal Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Esophageal Cancer - Pipeline Review, H2 2014, provides an overview of the Esophageal Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Esophageal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Esophageal Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014
Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014" provides data on the Complicated Intra-Abdominal Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Complicated Intra-Abdominal Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Complicated Intra-Abdominal Infections.
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Dementia - Pipeline Review, H2 2014
Dementia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Dementia - Pipeline Review, H2 2014, provides an overview of the Dementias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dementia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014
Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014" provides data on the Gram-Negative Bacterial Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gram-Negative Bacterial Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gram-Negative Bacterial Infections. This report is buil
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Post-Operative Pain - Pipeline Review, H2 2014
Post-Operative Pain - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Post-Operative Pain - Pipeline Review, H2 2014, provides an overview of the Post-Operative Pains therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Operative Pain and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014
Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014" provides data on the Gram-Positive Bacterial Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gram-Positive Bacterial Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gram-Positive Bacterial Infections. This report is buil
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014, provides an overview of the Retinitis Pigmentosa (Retinitis)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinitis Pigmentosa (Retinitis) and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
H1N1 Infection Global Clinical Trials Review, H2, 2014
H1N1 Infection Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, H1N1 Infection Global Clinical Trials Review, H2, 2014" provides data on the H1N1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H1N1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H1N1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014
Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2014, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Recurrent Glioblastoma Multiforme (GBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Recurrent Glioblastoma Multiforme (GBM) and special features on late-stage and discontinued projects.Global Markets
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014" provides data on the H5N1 Infection (Avian Influenza) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H5N1 Infection (Avian Influenza). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H5N1 Infection (Avian Influenza). This report is built using da
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014, provides an overview of the Chemotherapy Induced Neutropenias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Neutropenia and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014
Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014" provides data on the Hand, Foot And Mouth Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hand, Foot And Mouth Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hand, Foot And Mouth Disease. This report is built using data and information s
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Critical Limb Ischemia - Pipeline Review, H2 2014
Critical Limb Ischemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Critical Limb Ischemia - Pipeline Review, H2 2014, provides an overview of the Critical Limb Ischemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Critical Limb Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Critical Limb Ischemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000
Hemorrhagic Fever Global Clinical Trials Review, H2, 2014
Hemorrhagic Fever Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hemorrhagic Fever Global Clinical Trials Review, H2, 2014" provides data on the Hemorrhagic Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Fever. This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Thyroid Cancer - Pipeline Review, H2 2014
Thyroid Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Thyroid Cancer - Pipeline Review, H2 2014, provides an overview of the Thyroid Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thyroid Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Nov 2014
Published By: Global Markets Direct

Price: $2000